Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 677-683

  Cappelletty, Diane M ^a   Rybak, Michael J ^a,b,c  

^a Department of Pharmacy   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFICACY; DRUG MIXTURE; DRUG POTENTIATION; DRUG SCREENING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0030069091     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.677     Document Type: Article

References (21)

1. Arpi, M. 1988. Time-kill studies and synergy testing of broad-spectrum antibiotics against blood culture isolates. Chemotherapy (Basel) 34:393-400.
2. Baltch, A. L., C. Bassey, M. C. Hammer, R. P. Smith, J. V. Conroy, and P. B. Michelsen. 1991. Synergy with cefsulodin or piperacillin and three aminoglycosides or aztreonam against aminoglycoside resistant strains of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 27:801-808.
3. Chandrasekar, P. H., L. R. Crane, and E. J. Bailey. 1987. Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients. J. Antimicrob. Chemother. 19:321-329
4. Chin, N. X., and H. C. Neu. 1989. Synergy of new C-3 substituted cephalosporins and tobramycin against Pseudomonas aeruginosa and Pseudomonas cepacia Diagn. Microbiol Infect. Dis. 12:343-349.
5. Glew, R. H., and R. A. Pavuk. 1984. Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae. Antimicrob. Agents Chemother. 26:378-381.
6. Greco, W. R., H. S. Park, and Y. M. Rustum. 1990. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-β-D-arabinofuranosylcytosine. Cancer Res. 50:5318-5327.
7. Haag, P., P. Lexa, and I. Werkhäuser. 1986. Artifacts in dilution pharmacokinetic models caused by adherent bacteria. Antimicrob Agents Chemother. 29:765-768.
8. Hancock, R. E., V. J. Raffle, and T. I. Nicas. 1981. Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 19:777-785.
9. Kapotas, N. M. 1991. Acclimatization resistance of a Pseudomonas aeruginosa prototype stiam to imipenem. J. Antibiot. 44:985-994
10. Lagast, H., A. Pascual-Lopez, P. Dejace, and J. Klastersky. 1986. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test. Eur. J. Clin. Microbiol. 5:98-102.
11. Lerner, S., E. J. Dudek, W. E. Boisvert, and K. D. Berndt. 1984 Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa. Rev. Infect. Dis. 6(Suppl.):S678-S688.
12. Loewe, S. 1938. Coalative actions of combined drugs. J. Pharmacol. 63:24.
13. Loewe, S. 1953. The problem of synergism and antagonism of combined drugs. Arzneim. Forsch. 3:285-320.
14. Loewe, S. 1957. Antagonism and antagonists. Pharmacol. Rev. 9:237-242.
15. Lorian, V. 1991 Antibiotics in laboratory medicine. Laboratory methods used to assess the activity of antimicrobial combinations, 3rd ed., p. 434-444. The Williams & Wilkins Co., Baltimore.
16. Miller, M. H., S. A. Feinstein, and R. T. Chow. 1987. Early effects of beta-lactams on aminoglycoside uptake, bactericidal rates, and turbidimetrically measured growth in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 31:108-110.
17. National Committee for Clinical Laboratory Standards. 1990. Approved standard. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards. Villanova, Pa.
18. Norden, C. W. 1982. Problems in determination of antibiotic synergism in vitro. Rev. Infect. Dis. 4:276-281
19. Prichard, M. N., and C. Shipman, Jr. 1990. A three-dimensional model to analyze drug-drug interactions. Antiviral Res 14:181-206.
20. Rand, K. H., H. J. Houck, P. Brown, and D. Bennett. 1993. Reproducibility of the microdilution checkerboard method for antibiotic synergy. Antimicrob. Agents Chemother. 37:613-615.
21. Webb, J. L. 1963 Enzyme and metabolic inhibitors, vol 1 , p. 55-79, 488-512. Academic Press, Inc., New York